SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-014617
Filing Date
2024-02-12
Accepted
2024-02-12 16:06:04
Documents
1
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm245876-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm245876-5_4seq1.xml 4 4159
  Complete submission text file 0001104659-24-014617.txt   5767
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139
Business Address
Milne Jill C. (Reporting) CIK: 0001644246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 24619891